ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
3,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
4,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
4,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
6,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
7,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
9,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
10,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
11,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
12,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
13,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
14,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
15,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
15,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
16,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
16,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
16,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
16,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
17,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
19,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
19,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
20,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
21,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
21,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
24,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
25,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
26,1,Migraine,Migraine headaches,Headaches,Nerv,N
27,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
28,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
30,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
31,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
32,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
33,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
34,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
35,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
35,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
36,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
37,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
37,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
37,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
37,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
37,5,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
37,6,Staphylococcal skin infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
37,7,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
38,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
38,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
39,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
40,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
41,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
41,2,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
42,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
42,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
42,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
43,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
43,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
43,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
43,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
43,5,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
44,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
44,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
44,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
44,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
44,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
44,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
45,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
45,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
46,1,Acrochordon,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
46,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
46,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
47,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
47,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
47,3,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
48,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
48,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
48,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
48,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
49,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
49,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
50,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
51,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
51,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
52,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,3,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
53,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
53,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
53,3,Melanoderma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
53,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
54,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
55,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
55,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
56,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
57,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
57,2,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
57,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
57,4,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
57,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
57,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
57,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
57,8,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
57,9,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
57,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
58,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
59,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
59,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
59,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
60,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
60,2,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
60,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
60,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
60,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
60,6,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
61,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
61,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
61,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
61,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
61,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
62,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
62,3,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
62,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
62,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
63,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
63,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
64,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
64,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
64,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
65,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
65,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
65,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
65,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
65,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
65,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
65,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
66,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
66,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
66,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
66,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
66,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
67,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
67,2,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
68,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
68,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
69,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
70,1,Migraine,Migraine headaches,Headaches,Nerv,N
70,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
71,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,3,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
71,4,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
71,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
72,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
73,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
74,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
74,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
74,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
75,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
76,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
77,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
78,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
79,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
79,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
79,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
80,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
81,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
83,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
83,2,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
84,1,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
84,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
84,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
85,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
86,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
87,1,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
87,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
87,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
88,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
88,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
89,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
89,2,Hair injury,Skin injuries NEC,Injuries NEC,Inj&P,N
89,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
90,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
91,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
91,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
92,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
94,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
94,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
95,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
96,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
96,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
96,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
97,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
97,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
97,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
97,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
97,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
98,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
98,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
99,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
99,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
99,3,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
99,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
99,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
99,6,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
101,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
101,2,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
101,3,Chemical burns of eye,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
101,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
102,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
102,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
103,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
103,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
104,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
105,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
105,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
105,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
106,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
106,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
106,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
107,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
108,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
108,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
108,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
109,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
109,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
109,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
109,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
109,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
110,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
110,2,Hair dye user,Social issues NEC,Lifestyle issues,SocCi,N
111,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
112,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
112,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
113,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
113,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
114,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
114,2,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
114,3,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
114,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
114,5,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
114,6,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
115,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
116,1,Headache,Headaches NEC,Headaches,Nerv,N
116,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
116,3,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
117,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
118,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
120,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
121,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
121,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
121,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
122,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
122,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
122,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
124,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
124,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
124,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
125,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
125,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
125,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
125,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
125,5,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
125,6,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
125,7,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
126,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
127,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
128,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
129,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
129,3,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
130,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
131,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
132,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
132,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
132,3,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
133,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
133,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
134,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
135,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
135,4,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
135,5,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
136,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
136,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
136,3,Headache,Headaches NEC,Headaches,Nerv,N
136,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
137,1,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
138,1,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
139,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
140,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
141,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
142,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
143,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
143,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
144,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
144,2,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
145,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
145,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
146,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
147,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
148,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
149,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
150,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
150,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
150,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
151,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
152,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
152,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
153,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
153,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
154,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
155,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
156,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
156,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
156,3,Hair disorder,Pilar disorders NEC,Skin appendage conditions,Skin,N
157,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
157,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
157,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
157,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
158,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
159,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
160,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
160,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
161,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
162,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
163,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
163,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
163,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
164,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
164,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
165,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
165,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
166,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
166,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
167,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
167,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
168,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
169,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
170,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
170,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
170,3,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
170,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
171,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
172,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
173,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
173,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
174,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
174,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
174,3,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
175,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
176,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
176,3,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
177,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
177,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
177,3,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
177,4,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
177,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
